Vaccine Hesitancy in China: A Qualitative Study of Stakeholders’ Perspectives
Abstract
:1. Introduction
2. Materials and Methods
3. Results
3.1. Perspectives on Vaccine Safety
The efficacy of vaccines produced by Changsheng decreased, but the safety of vaccines meets the standards, which means that it will not threaten citizens’ lives. (ID 1)
During the Changsheng vaccine crisis, regulatory bodies uncovered falsifying data for the rabies vaccine and then controlled these problematic vaccines promptly. No faulty vaccine was consumed by citizens. (ID 6)
Additionally, re-vaccination campaigns were conducted by the state to ensure that antibodies were produced. (ID 3)
Media reports included these casualties as a result of unsafe vaccine uptake and stimulated parental anxiety via rapid information dissemination online. (ID 2)
‘People cannot give up eating for fear of choking’. They should not hesitate to vaccinate. An effective crisis response should be conducted to mitigate public disquiet. (ID 5)
People may relax their vigilance and exercise less, as they believe that the antibodies produced after vaccination lead to decreased immunity, especially the invalid rabies vaccine, threatening people’s lives. (ID 10)
Meanwhile, changes in the contents of culture containers produce new, unknown substances which current technologies fail to assess, increasing risks in vaccine safety. (ID 11)
I saw the doctor throw vaccines on the table without cold storage and pile them randomly, which made me anxious about vaccine safety. During the vaccination, I kept asking: ‘Is this kind of vaccine—please don’t take it wrong—is it safe without cold storage?’ (ID 13)
The vaccine regulatory system is strict in China, but why were falsified vaccine quality reports from the Chansheng company failed to be screened by the state? State–business collusion and bribery should be to blame. (ID 18)
CDC experts are assigned with the responsibilities of immunization, epidemic-preventing and science popularisation regarding public health. When vaccination incidents occur, CDC experts are obliged to conduct crisis management and reassure the public. Additionally, CDC experts are able to release negative information concerning vaccination with the state permission, otherwise they will be accountable for damaging the reputation of the state (ID 10).
More vaccines should be freely provided by the CDC, more than 5% of vaccines should be selected for examination, and a strict administrative accountability mechanism should be conducted to impose punishments on manufacturers and officials. (ID 10)
3.2. Practical Organization of Vaccination
3.2.1. Signing Pre-Vaccination Informed Consent Forms
More than 80% of doctor-patient tensions result from unclear responsibility-defining. Informed consent signing clearly allocates blame and mitigates tensions. (ID 2)
Doctors will cautiously screen children’s health situations before vaccination, interact with the public about vaccination precautions, and record vaccination procedures. (ID 4)
Because informed consent stresses parental duties but neglects to define doctors’ responsibilities, I failed to hold doctors accountable after a side effect harmed my child. (ID 10)
Doctors ask parents to read vaccination information on the informed consent form instead of informing them of precautions. This way, they do not have to interact with parents. (ID 19)
All side reactions and remedies should be listed clearly, including the training that doctors have done to improve their social responsibility. (ID 20)
3.2.2. Single or Combined Shots
Combined vaccination may interfere with producing different antibodies, increasing adverse effects. On the contrary, a single shot is favourable to defining the responsibilities between CDC and the medical institution. (ID 2)
Doctors recommend combined shots, as children benefit from [them]. These commercial combined shots are around 4000¥, and I feel pressure to pay. I prefer the free single shot. ‘Free’ does not mean bad but is the best for my child. (ID 16)
Diphtheria, Tetanus, acellular Pertussis, Inactivated Polio Vaccine (DTaP-IPV), adopting advanced technologies to quantitatively ration antigenic components, ensures solubility, physical compatibility and stability. (ID 3)
Four doses of DTaP-IPV injection with children instead of 12 doses of single shots greatly reduces the number of side effects and saves time in visiting the hospital. (ID 11)
No manufacturers in China so far can produce the DTP vaccine, polio vaccine or DTaP-IPV vaccine. Therefore, the state should increase investment in technology innovation and promote the cooperation of manufacturers and research institutes to overcome technical bottlenecks and stimulate industrial upgrading. (ID 6)
3.2.3. Post-Vaccination Antibody Tests
Herd immunity greatly increases the efficiency and reduces the costs of vaccination programmes. As long as everyone can be vaccinated in a timely manner, individuals vulnerable to infection without antibodies will be protected, and the disease will inevitably be eliminated (ID 5).
Bacteria generated by uptake of live bacterial vaccines need to grow and multiply in individual bodies to activate the immune system, and there will be a skin reaction within 2–3 months, which indicates induced immunity. (ID 16)
During the Changsheng invalid vaccine incident in 2018, several local governments conducted re-vaccination campaigns, but they only increased the chances of side effects. I suggest testing antibodies first. (ID 12).
I took planes to go Hong Kong with my child and finish antibody testing on the same day. Then I received the report quickly. (ID 17)
While the cost of antibody tests in Hong Kong is expensive, antibody tests relate to public health. The state should build laboratories to provide test services. (ID 15)
3.3. Incident Response
3.3.1. Vaccine Incident Investigations
There is at least one clinical expert participating in data collection to obtain detailed information about children and doctors. (ID 4)
Experts eligible for risk assessment should have professional knowledge and extensive clinical experience and should be selected randomly from expert databases. Those who keep relations with victims and vaccinators should be excluded. (ID 2)
The CDC is not only the athlete but also the referee in the risk assessment, as risk assessment experts keep close ties with local CDCs and prioritise their interests (ID 19).
Experts make subjective decisions based on partial medical records and personal experience. (ID 18)
Parents know children’s health situations and witness vaccination procedures. Their involvement in risk assessment will contribute to better judgement, negotiation, information transparency and trust. (ID 11)
3.3.2. Information Disclosure
Laws have defined specific standards for information disclosure. To stimulate transparency, the state conducts rigorous annual evaluations at the local level. (ID 2)
During the hepatitis B vaccine [incident] in 2013, the government kept the investigation process transparent, which in turn fed public fear. (ID 7)
Public officials will not release unfavourable information, aiming to shirk responsibility. Experts will claim ‘coupling symptoms’ while keeping evaluation procedures, techniques and standards opaque. (ID 17)
The traceability mechanism records details of crisis management to keep information relevant to victims, vaccination, diagnosis, data collection and risk assessment. Live streaming can be adopted to ensure the procedure’s transparency. (ID10)
3.3.3. Diagnosing Adverse Effects: ‘Coupling’ or ‘Malpractice’
‘Coupling’ is a personal health problem in which a disease is incubated before vaccination and arises even without vaccination. Parents should be blamed, as they do not read the contraindications precisely, do not provide children’s health situations and do not follow guidelines. (ID 2)
These vaccines are safe. The qualifications of doctors, information records of vaccination, and equipment meet the standards. (ID 7)
Doctors who are unable to provide logical evidences to substantiate their vaccination behaviours should be accountable for vaccine incidents. (ID 11)
There were seventeen vaccine cases all diagnosed as coupling in 2017, not related to vaccination, causing public distrust. (ID 14)
The complexity of personal physiques, the professionalism of vaccination and environmental vulnerability all make it difficult to allocate blame. The state should provide more financial relief instead of responsibility-defining. (ID 6)
Terms for applying compensation are extremely harsh, and victims get less compensation [as a result]. Financial relief should be improved, including for coupling and general reaction, procedures [should be simplified], and commercial insurance [should be introduced]. (ID 16)
4. Discussion
Limitations of this Research
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- The Lancet Child & Adolescent Health. Vaccine hesitancy: A generation at risk. Lancet 2019, 3, 281. [Google Scholar]
- Yang, R.; Penders, B.; Horstman, K. Addressing Vaccine Hesitancy in China: A Scoping Review of Chinese Scholarship. Vaccines 2020, 8, 2. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cao, L.; Zheng, J.; Cao, L.; Cui, J.; Xiao, Q. Evaluation of the impact of Shandong illegal vaccine sales incident on immunizations in China. Hum. Vaccines Immunother. 2018, 14, 1672–1678. [Google Scholar] [CrossRef] [PubMed]
- Zhang, S. Experience of the Shanxi vaccine incident. China Public Health Manag. 2010, 6, 18–19. [Google Scholar]
- Chen, B.; Zhang, J.M.; Jiang, Z.; Shao, J.; Jiang, T.; Wang, Z.; Liu, K.; Tang, S.; Gu, H.; Jiang, J. Media and public reactions toward vaccination during the ‘hepatitis B vaccine crisis’ in China. Vaccine 2015, 33, 1780–1785. [Google Scholar] [CrossRef] [PubMed]
- Chen, G.; Lai, R. China’s Vaccine Scandal 2018: Pharmaceutical Companies Facing Heightened Regulatory Risks; EAI Background Brief No. 1386; East Asian Institute, National University of Singapore: Singapore, 2018; pp. 1–3. [Google Scholar]
- Liu, S. Improving vaccine supervision system in China after Shangdong vaccine crisis. Mod. Econ. Inf. 2016, 14, 12–14. [Google Scholar]
- Chinese Administrative Management Group. Balancing state supervision and market: Challenge and countermeasures of vaccine safety. Chin. Adm. Manag. 2018, 400, 8–14. [Google Scholar]
- Shanghai CDC. Vaccine Abnormal Response Rate is Less than 1%. China Youth Network. 2016. Available online: http://www.sohu.com/a/65119558119038 (accessed on 24 April 2019).
- Wang, X.; Zhou, X.; Leesa, L.; Mantwill, S. The effect of vaccine literacy on parental trust and intention to vaccinate after a major vaccine scandal. J. Health Commun. 2018, 23, 413–421. [Google Scholar] [CrossRef] [PubMed]
- Liu, X.; Hu, W.; Zhang, S. The trust degree of parents on the Shanxi vaccination program affected by the Shandong vaccine crisis in 2016. J. China Vaccine Immun. 2018, 24, 83–88. [Google Scholar]
- Cheng, M.; Su, Z.; Lian, Q. Study on the effect of vaccination informing on the rate of vaccination adverse reactions. Lab. Med. Clin. 2014, 5, 706–707. [Google Scholar]
- Liu, F. Discussion on the application of mother classroom in vaccination. Henan J. Prev. Med. 2015, 5, 100–101. [Google Scholar]
- Qiao, X.; Wei, J.; Lu, D. Analysis of influencing factors of vaccination. Int. J. Epidemiol. Infect. 2018, 45, 436–440. [Google Scholar]
- Wang, L.D.L.; Lam, W.W.T.; Wu, J.T.; Liao, Q.; Fielding, R. Chinese immigrant parents’ vaccination decision making for children: A qualitative analysis. BMC Public Health 2014, 14, 1–13. [Google Scholar] [CrossRef] [Green Version]
- Guo, W.; Wang, J.; Yu, X. Investigation on the willingness and inflfluencing factors of EV71 vaccine for vaccination medical staff in Dezhou City. J. Prev. Med. 2018, 3, 171–173. [Google Scholar]
- Yu, W.; Liu, D.; Zheng, J.; Liu, Y.; An, Z.; Wang, F. Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China. Int. J. Epidemiol. 2016, 45, 441–449. [Google Scholar] [CrossRef] [Green Version]
- Zhou, M.; Qu, S.; Zhao, L.; Kong, N.; Campy, K.S.; Wang, S. Trust collapse caused by the Changsheng vaccine crisis in China. Vaccine 2019, 37, 3419–3425. [Google Scholar] [CrossRef]
- Zhao, X.; Zhou, L.; Yang, X. Investigation on the influence of hepatitis B vaccine incident on hepatitis B vaccination rate and cognitive attitude of parents in hepatitis B vaccine in Jinan City. China Community J. 2016, 4, 186–187. [Google Scholar]
- Small, M.L. ‘How many cases do I need?’: On science and the logic of case selection in field-based research. Ethnography 2009, 10, 5–38. [Google Scholar] [CrossRef]
- Saunders, B.; Sim, J.; Kingstone, T.; Baker, S.; Waterfield, J.; Bartlam, B.; Burroughs, H.; Jinks, C. Saturation in qualitative research: Exploring its conceptualization and operationalization. Qual. Quant. 2018, 52, 1893–1907. [Google Scholar] [CrossRef]
- Morse, J.M. The significance of saturation. Qual. Health Res. 1995, 5, 147–149. [Google Scholar] [CrossRef]
- Millar, R.; Tracey, A. The Interview Approach. In Auditing Organizational Communication: A Handbook of Research, Theory and Practice; Routledge: London, UK, 2009; pp. 78–102. [Google Scholar]
- Heimer, M.; Thøgersen, S. Doing Fieldwork in China; University of Hawaii Press: Honolulu, HI, USA, 2006. [Google Scholar]
- Xu, W.; Yang, M. Crisis and Turnaround of Government Supervision in the Fragmentation of New Media Information. Mod. Inf. 2014, 6, 50–57. [Google Scholar]
- Guest, G.; MacQueen, K.M.; Namey, E.E. Applied Thematic Analysis; Sage Publications: Thousand Oaks, CA, USA, 2011. [Google Scholar]
- Durant, J.; Evans, G.; Thomas, G. Public understanding of science in Britain: The role of medicine in the popular representation of science. Public Underst. Sci. 1992, 1, 161–182. [Google Scholar] [CrossRef]
- Gross, A.G. The roles of rhetoric in the public understanding of science. Public Underst. Sci. 1994, 3, 3–23. [Google Scholar] [CrossRef]
- Geelen, E.; Vliet, H.; de Hoogh, P.; Horstman, K. Taming the fear of voice: Dilemmas in maintaining a high vaccination rate in the Netherlands. Soc. Sci. Med. 2016, 153, 12–19. [Google Scholar] [CrossRef]
- Hobson-West, P. Understanding vaccination resistance: Moving beyond risk. Health Risk Soc. 2003, 5, 273–283. [Google Scholar] [CrossRef]
- Brossard, D.; Lewenstein, B.V. A Critical Appraisal of Models of Public Understanding of Science: Using Practice to Inform Theory. In Communicating Science: New Agendas in Communication; Routledge: New York, NY, USA, 2010. [Google Scholar]
- Goldenberg, M.J. Public misunderstanding of science? Reframing the problem of vaccine hesitancy. Perspect. Sci. 2016, 24, 552–581. [Google Scholar] [CrossRef]
- Chen, F.; Shi, Y.; Xu, F. An analysis of the Public Scientific Literacy study in China. Public Underst. Sci. 2009, 18, 607–616. [Google Scholar] [CrossRef]
- Zhang, J.Y. The ‘credibility paradox’ in China’s science communication: Views from scientific practitioners. Public Underst. Sci. 2015, 24, 913–927. [Google Scholar] [CrossRef] [Green Version]
- Fang, X. Local people’s understanding of risk from civil nuclear power in the Chinese context. Public Underst. Sci. 2013, 23, 283–298. [Google Scholar] [CrossRef]
- Jia, H.; Liu, L. Unbalanced progress: The hard road from science popularisation to public engagement with science in China. Public Underst. Sci. 2014, 23, 32–37. [Google Scholar] [CrossRef] [PubMed]
- Liang, J.; Liu, X.; Zhang, W. Scientists vs laypeople: How genetically modified food is discussed on a Chinese Q&A website. Public Underst. Sci. 2019, 28, 991–1004. [Google Scholar]
- Zvonareva, O.; Popova, E.; Horstman, K. Health, Technologies, and Politics in Post-Soviet Settings: Navigating Uncertainities; Springer: Cham, Switzerland, 2018. [Google Scholar]
- Penders, B. Vaccines, science and trust. Nat. Microbiol. 2017, 2, 1. [Google Scholar] [CrossRef]
- Gjorgjieva, J.; Smith, K.; Chowell, G.; Sánchez, F.; Snyder, J.; Castillo-Chavez, C. The role of vaccination in the control of SARS. Math. Biosci. Eng. 2005, 2, 753–769. [Google Scholar] [CrossRef]
- Piltch-Loeb, R.; DiClemente, R. The vaccine uptake continuum: Applying social science theory to shift vaccien hesitancy. Vaccines 2020, 8, 76. [Google Scholar] [CrossRef] [Green Version]
- Xue, L. The role of science in public decision-making: Focusing on the risk research and judgment mechanism in public health events. Stud. Sci. Sci. 2020, 38, 385–387. [Google Scholar]
- Wagner, A.L.; Masters, N.B.; Domek, G.J.; Mathew, J.L.; Sun, X.; Asturias, E.J.; Ren, J.; Huang, Z.; Contreras-Roldan, I.L.; Gebremeskel, B.; et al. Comparisons of vaccine hesitancy across five low-and middle-income countries. Vaccines 2019, 7, 155. [Google Scholar] [CrossRef] [Green Version]
- Xiao, Z.; Wang, C.; Wang, Y. Qualitative research on vaccination knowledge, attitude and behavior of child guardians in rural areas. Chin. Prim. Health Care 2015, 29, 73–75. [Google Scholar]
- Zhu, S.; Chang, J.; Ji, W. Investigation on Parents’ Attitudes and Hesitation to Child Vaccination in Xi’an. Chin. Pharm. Aff. 2018, 32, 136–141. [Google Scholar]
- Scott, J.C. Seeing Like a State: How Certain Schemes to Improve the Human Condition Have Failed; Yale University Press: London, UK, 1998. [Google Scholar]
Interviewee ID | Gender | Description of Function |
---|---|---|
ID 1 | Female | Expert in Shanghai CDC |
ID 2 | Female | Expert in Xinyang CDC |
ID 3 | Male | Clinician in Shanghai Tenth People’s Hospital |
ID 4 | Male | Clinician in Wuhan Union Hospital Vaccination Clinic |
ID 5 | Female | Clinician in Xinyang Central Hospital |
ID 6 | Female | Clinician at Children’s Health Clinic in Xinyang First People’s Hospital |
ID 7 | Female | Clinician in Shanghai Hongkou Community Healthcare Service |
ID 8 | Male | Clinician in Xinyang Community Healthcare Service |
ID 9 | Male | Clinician in Wuhan Biotechnology Co., Ltd. |
ID 10 | Male | Online medical expert |
ID 11 | Male | Online medical expert |
ID 12 | Male | Journalist in Wuhan Jingchu media |
ID 13 | Female | Journalist in Xinyang Economic Daily media |
ID 14 | Female | Mom with a 5-year-old daughter |
ID 15 | Male | 50-year-old man, suffered from infantile paralysis in childhood |
ID 16 | Female | Mom with a 1-year-old son |
ID 17 | Male | Father with two children |
Informant ID | Gender | Function | UCL |
---|---|---|---|
ID 18 | Male | Self-defined victim: Parent with a child who suffered from disability after Polio vaccination | http://bbs.tianya.cn/post-free-4708430-1.shtml |
ID 19 | Female | Self-defined victim: Parent with a daughter who suffered epilepsy after rabies vaccination | http://bbs.tianya.cn/post-develop-2334312-1.shtml |
ID 20 | Female | Self-defined victim: Parent with a baby who suffered infantile spasms after DPT vaccination | https://www.weibo.com/ttarticle/p/show?id=2309404181411853683814 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yang, R.; Penders, B.; Horstman, K. Vaccine Hesitancy in China: A Qualitative Study of Stakeholders’ Perspectives. Vaccines 2020, 8, 650. https://doi.org/10.3390/vaccines8040650
Yang R, Penders B, Horstman K. Vaccine Hesitancy in China: A Qualitative Study of Stakeholders’ Perspectives. Vaccines. 2020; 8(4):650. https://doi.org/10.3390/vaccines8040650
Chicago/Turabian StyleYang, Ronghui, Bart Penders, and Klasien Horstman. 2020. "Vaccine Hesitancy in China: A Qualitative Study of Stakeholders’ Perspectives" Vaccines 8, no. 4: 650. https://doi.org/10.3390/vaccines8040650
APA StyleYang, R., Penders, B., & Horstman, K. (2020). Vaccine Hesitancy in China: A Qualitative Study of Stakeholders’ Perspectives. Vaccines, 8(4), 650. https://doi.org/10.3390/vaccines8040650